Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study

RATIONALE & OBJECTIVE: Individuals with chronic kidney disease frequently suffer from chronic kidney disease-associated pruritus (CKD-aP), impacting sleep quality and quality of life (QoL) and increasing the likelihood of depression. Difelikefalin is a kappa-opioid receptor agonist recently appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiner, Daniel E., Vervloet, Marc G., Walpen, Sebastian, Schaufler, Thilo, Munera, Catherine, Menzaghi, Frédérique, Wen, Warren, Bhaduri, Sarbani, Germain, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516453/
https://www.ncbi.nlm.nih.gov/pubmed/36185706
http://dx.doi.org/10.1016/j.xkme.2022.100542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516453/
https://www.ncbi.nlm.nih.gov/pubmed/36185706
http://dx.doi.org/10.1016/j.xkme.2022.100542

Ejemplares similares